The identification of moulds by means of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been evaluated repeatedly for use in clinical diagnostic settings. 1 However, recommended protocols are based on the analysis of time-consuming subcultures rather than primary growth obtained on solid isolation media.
The identification of moulds by means of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been evaluated repeatedly for use in clinical diagnostic settings. 1 However, recommended protocols are based on the analysis of time-consuming subcultures rather than primary growth obtained on solid isolation media.
In order to compare the identification performance of MALDI-TOF MS applied to primary colonies (protocol A) versus subculture samples (protocol B), 111 reference specimens representing 30 clinically relevant species were analyzed. Each of these species was identified, at least once, by internal transcribed spacer (ITS) sequence analysis, which was considered the gold standard in this study (Table 1 ). In addition, each of the 111 strains was identified by phenotype testing.
In protocol A, primary growth on Sabouraud agar (Difco Sabouraud Agar, Modified) after 24 to 72 h of incubation (time required for the first visible mycelium growth) was collected carefully, avoiding agar, by means of a wooden toothpick. The biomass was deposited on an unpolished target plate, air-dried, and overlaid with 1 ml alpha-cyano-4-hydroxycinnamic acid.
In protocol B, and in accordance with the Bruker protocol, the filamentous fungi were inoculated in 8 ml of Sabouraud liquid broth (Difco Sabouraud Maltose Broth), which was rotated overnight at room temperature. The sediments of overnight subcultures were washed thoroughly, extracted with acetonitrile-formic acid, and then 1 ml of supernatant was placed onto an unpolished target plate and processed further, as above.
MALDI-TOF MS was performed using a Microflex LT instrument and Biotyper software in conjunction with Filamentous Fungi library version 1.0 (Bruker). As per the manufacturer's recommendation, a score of 2.0 indicates confident species-level (or species group-level) identification, a score of 1.7-1.99 indicates confident genus-level identification, and a score of <1.7 is considered unreliable. 2 The following species and species groups gave confident and comparable identification scores using either protocol A or B, and were identified correctly (designation according to Bruker): Aspergillus flavus (n = 8), A. fumigatus (n = 37), A. nidulans (n = 4), A. niger (n = 13), A. ochraceus (n = 1), A. terreus (n = 5), A. ustus (n = 2), A. versicolor (n = 1), Cladosporium herbarum (n = 1), Exophiala dermatitidis (n = 1), Fusarium dimerum (n = 2), F. oxysporum (n = 1), F. solani (n = 4), Lichtheimia corymbifera (n = 4), Mucor circinelloides (n = 2), Paecilomyces lilacinus (n = 1), P. variotii (n = 1), Penicillium chrysogenum (n = 4), P. citrinum (n = 1), Rhizomucor pusillus (n = 1), Rhizopus microsporus (n = 2), R. oryzae (n = 1), Scedosporium apiospermum (n = 6), S. prolificans (n = 1), S. brevicaulis (n = 1).
However, Coprinellus marculentus, Neoscytalidium dimidiatum, Neurospora tetrasperma, Phialemonium obovatum, and Scytalidium hyalinum were not identified reliably due to the lack of corresponding reference entries in the database.
Schulthess et al. 2 showed that lowering the cut-off from 2 to >1.7 for a species-level identification resulted in no misidentifications. Applying that condition to our results, and in agreement with the findings of Schulthess et al., the overall percentage of correct identification increased from 68.7% to 76.4% and from 63.6% to 75.15% for protocols A and B, respectively ( Table 2) .
Protocol A was then applied prospectively for primary growth derived from 49 clinical samples, which included respiratory specimens (n = 36), swabs (n = 10), and other specimens (n = 3), using a cut-off value of >1.7 for confident identification. Forty-four specimens exhibited a score >1.7 (71.6%) and were identified correctly by MALDI-TOF MS. Among these 44 filamentous fungi, three were confirmed by ITS sequence analysis, as they had not been identified previously in clinical specimens in our laboratory (Alternaria alternata, Chaetomium globosum, and Fusarium proliferatum). The remaining five specimens gave unreliable scores. Nevertheless, for four of them, the identification suggested by MALDI-TOF MS (Aspergillus niger, score 1.60; Aspergillus unguis, score 1.51; Scedosporium apiospermum, score 1.50; Rhizopus oryzae, score 1.56) was confirmed by ITS sequence analysis. One specimen without a reliable score could not be identified by MALDI-TOF MS because of the lack of reference data for Uncinocarpus queenslandicus, the agent present (Table 3) . In conclusion, confident identification of filamentous fungi by MALDI-TOF MS is feasible without subculture of primary growth. We emphasize that this approach requires biomass free of culture medium, which may negatively impact MALDI-TOF MS identification. These findings may further support the implementation of MALDI-TOF MS in the clinical setting in order to achieve rapid and reliable diagnosis of fungal agents.
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